Regulation of islet beta-cell proliferation by prolactin in rat islets
- PMID: 7904577
- DOI: 10.2337/diab.43.2.263
Regulation of islet beta-cell proliferation by prolactin in rat islets
Abstract
This study examined the effects of prolactin on beta-cell proliferation in pancreatic islet of Langerhans. Insulin secretion and beta-cell proliferation were significantly increased from neonatal rat islets cultured for 4 days in the presence of either 500 ng/ml ovine prolactin (oPRL) or rat prolactin (rPRL). These effects could be prevented by including anti-oPRL serum in the culture media. Although insulin secretion and beta-cell proliferation were slightly higher during the first 24 h of exposure to rPRL, maximal response was observed after 4 days for insulin secretion and 6-10 days for beta-cell proliferation. The initial mitogenic response of beta-cell to rPRL occurred by the limited recruitment of nondividing beta-cells into the cell cycle and by most daughter cells proceeding directly into additional cell division cycles. Subsequently, the maximal effect of rPRL on beta-cell proliferation was maintained by a higher rate of recruitment of previously nondividing beta-cells into cell cycle with only one fourth of the daughter cells continuing to divide. These observations are difficult to reconcile with the proposal that a limited pool of beta-cells capable of undergoing cell division exists in islets. Instead, these observations suggest that individual beta-cells are transiently re-entering the cell cycle and dividing infrequently in response to rPRL. In this case, the majority of the beta-cells would not be expected to be in an irreversible Go phase. We also demonstrated that the effects of rPRL on beta-cell proliferation occur at normal serum glucose concentrations and are affected by inhibitors of polyamine metabolism. Additional studies on the effects of rPRL on beta-cells should provide important information on the regulation of beta-cell proliferation during conditions of increased insulin demand.
Similar articles
-
Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy.Endocrinology. 1993 Nov;133(5):2227-34. doi: 10.1210/endo.133.5.8404674. Endocrinology. 1993. PMID: 8404674
-
Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy.Endocrinology. 1993 Feb;132(2):879-87. doi: 10.1210/endo.132.2.8425500. Endocrinology. 1993. PMID: 8425500
-
Role of prolactin versus growth hormone on islet B-cell proliferation in vitro: implications for pregnancy.Endocrinology. 1991 Jan;128(1):45-57. doi: 10.1210/endo-128-1-45. Endocrinology. 1991. PMID: 1986937
-
Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones.Horm Metab Res. 1997 Jun;29(6):301-7. doi: 10.1055/s-2007-979040. Horm Metab Res. 1997. PMID: 9230352 Review.
-
The role of growth hormone and prolactin in beta cell growth and regeneration.Adv Exp Med Biol. 1992;321:9-17; discussion 19-20. doi: 10.1007/978-1-4615-3448-8_2. Adv Exp Med Biol. 1992. PMID: 1449086 Review. No abstract available.
Cited by
-
Could low prolactin levels after radiotherapy predict the onset of hypopituitarism?Rev Endocr Metab Disord. 2024 Dec;25(6):1013-1025. doi: 10.1007/s11154-024-09900-1. Epub 2024 Aug 22. Rev Endocr Metab Disord. 2024. PMID: 39172174 Free PMC article. Review.
-
Physiological insights gained from gene expression analysis in obesity and diabetes.Annu Rev Nutr. 2010 Aug 21;30:341-64. doi: 10.1146/annurev.nutr.012809.104747. Annu Rev Nutr. 2010. PMID: 20415584 Free PMC article. Review.
-
Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells.Islets. 2011 Nov-Dec;3(6):358-66. doi: 10.4161/isl.3.6.17923. Epub 2011 Nov 1. Islets. 2011. PMID: 21964314 Free PMC article.
-
The beneficial metabolic actions of prolactin.Front Endocrinol (Lausanne). 2022 Sep 23;13:1001703. doi: 10.3389/fendo.2022.1001703. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36213259 Free PMC article. Review.
-
Metabolic effects of prolactin and the role of dopamine agonists: A review.Front Endocrinol (Lausanne). 2022 Sep 30;13:1002320. doi: 10.3389/fendo.2022.1002320. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246929 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical